Rubiaceae · bark
Yohimbe
Pausinystalia johimbe
Bark mapped as a toxicity-leaning restricted entry because marketing still sells it for libido and fat loss. NCCIH-class summaries do not support unsupervised use.
Safety first
Yohimbine is an alpha-2 antagonist: hypertension, tachycardia, anxiety, priapism reports. MAOI and stimulant stacking is dangerous. Not a gym supplement. Restricted / professional-adjacent; dietary products are poorly assayed.
This entry exists so you do not use the plant casually. It is not a treatment suggestion.
Tradition vs trials
Traditional record. West African bark that became a 20th-century Western drug/supplement object. Traditional use is not a safety file.
Trial literature. Yohimbine has human autonomic and some erectile-dysfunction pharmacology. Adverse-event reports dominate the educational story.
Practical ranges
Educational ranges — not a prescription. Culinary use is not an extract.
bark / yohimbine
No unsupervised range in this catalog
NCCIH / FDA-era supplement warnings — Educational range only — not a prescription. A licensed clinician individualizes product, dose, and duration.
Pregnancy, nursing, children
- Pregnancy. Avoid.
- Nursing. Avoid.
- Children. Avoid.
Contraindications
- uncontrolled hypertension
- panic disorder
- unsupervised sexual-enhancement use
Key interactions
- MAOIs / decongestants / stimulants / antidepressants · contraindicated
Pressor and psychiatric stacking.